NIP
ITCI
Nicholas Investment Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-176,870
| Closed | -$14.8M | – | 243 |
|
|
2024
Q4 | $14.8M | Buy |
176,870
+22,072
| +14% | +$1.84M | 1.3% | 10 |
|
|
2024
Q3 | $11.3M | Buy |
154,798
+3,389
| +2% | +$248K | 1.04% | 22 |
|
|
2024
Q2 | $10.4M | Buy |
151,409
+80,038
| +112% | +$5.48M | 1.08% | 22 |
|
|
2024
Q1 | $4.94M | Buy |
71,371
+21,127
| +42% | +$1.46M | 0.51% | 71 |
|
|
2023
Q4 | $3.6M | Sell |
50,244
-285,310
| -85% | -$20.4M | 0.42% | 90 |
|
|
2023
Q3 | $17.5M | Sell |
335,554
-163,949
| -33% | -$8.54M | 1.31% | 24 |
|
|
2023
Q2 | $31.6M | Buy |
+499,503
| New | +$31.6M | 2.16% | 10 |
|
|
2023
Q1 | – | Sell |
-413,507
| Closed | -$21.9M | – | 218 |
|
|
2022
Q4 | $21.9M | Buy |
413,507
+22,829
| +6% | +$1.21M | 1.92% | 7 |
|
|
2022
Q3 | $18.2M | Sell |
390,678
-43,281
| -10% | -$2.01M | 1.69% | 9 |
|
|
2022
Q2 | $24.8M | Sell |
433,959
-128,414
| -23% | -$7.33M | 2.34% | 2 |
|
|
2022
Q1 | $34.4M | Sell |
562,373
-90,513
| -14% | -$5.54M | 2.45% | 1 |
|
|
2021
Q4 | $34.2M | Buy |
652,886
+39,674
| +6% | +$2.08M | 2.16% | 1 |
|
|
2021
Q3 | $22.9M | Buy |
613,212
+14,951
| +2% | +$557K | 1.67% | 7 |
|
|
2021
Q2 | $24.4M | Buy |
598,261
+43,716
| +8% | +$1.78M | 1.53% | 8 |
|
|
2021
Q1 | $18.8M | Buy |
554,545
+164,256
| +42% | +$5.57M | 1.31% | 24 |
|
|
2020
Q4 | $12.4M | Sell |
390,289
-67,431
| -15% | -$2.14M | 0.96% | 33 |
|
|
2020
Q3 | $11.7M | Buy |
+457,720
| New | +$11.7M | 1.27% | 25 |
|
|
2016
Q4 | – | Sell |
-43,181
| Closed | -$658K | – | 346 |
|
|
2016
Q3 | $658K | Sell |
43,181
-3,219
| -7% | -$49.1K | 0.04% | 292 |
|
|
2016
Q2 | $1.8M | Buy |
+46,400
| New | +$1.8M | 0.12% | 264 |
|
|
2015
Q3 | – | Sell |
-8,130
| Closed | -$260K | – | 330 |
|
|
2015
Q2 | $260K | Buy |
+8,130
| New | +$260K | 0.02% | 302 |
|